NCT00781053 - Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Skin Fibrosis

Interventions

DRUG

P144 cream

P144 cream 0.03% will be used once a day during the whole extension period of 6 months. The patient will apply the cream by him/herself or with a help of a person uniformly in a 10% maximum affected surface until absorption

Trial Locations (17)

10117

Allergie-Centrum-Charité, Abteilung für, Berlin

28041

Hospital 12 de Octubre, Madrid

31008

Clinica de Navarra, Pamplona

50139

Azienda Ospedaliera Universitaria Careggi, Florence

50937

Klinik und Poliklinik für Dermatologie und Vererologie, Cologne

60590

Klinikum der Johan Wolfgang Goethe-Universitat, Frankfurt

61231

Herz- und Rheumazentrum Kerckhoff-Klinik, Bad Hauheim

H-7621

Immunologiai es Reumatologiai Klinika, Pécs

15-297

Centrum Mirada, Bialystok

Unknown

Samodzielny Publiczny Szpital Kliniczny, Katowice

61-545

Katedra i Klinika Raumatologizno, Poznan

53-137

Gabinet Lekarski Internistyczno- Reumatologiezny, Wroclaw

41-803

Klinika Ftizjopneumonologii SAM, Zabrze

08036

Hospital Clinic i Provincial de Barcelona, Barcelona

NW3 2QG

Chapel Allerton Hospital, Leeds

Nw3 2QG

Royal Free Hospital, London

L9 7AL

University Hospital Aintree, Liverpool